跳至主要内容
临床试验/NCT06997887
NCT06997887招募中不适用

Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年5月9日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Female Sexual Function Index (FSFI) score

研究概览

简要总结

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.

详细描述

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index (FSFI) scores. Follow-up assessments will be conducted to determine whether CH2 vaginal gel or vaginal rehabilitation can improve post-radiotherapy vaginal health and enhance the long-term quality of life for women with cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients aged between 20 and 70 years.
  • Completion of pelvic radiotherapy for gynecologic cancer, which may include external beam radiotherapy (EBRT), brachytherapy (BT), or a combination of both.
  • Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1.

排除标准

  • Individuals under the age of
  • Presence of distant metastases or a history of malignancy currently under treatment within the past five years (excluding non-melanoma skin cancer).
  • Presence of severe comorbidities, such as uncontrolled diabetes, cardiovascular disease, or autoimmune disorders that may interfere with treatment or study participation.
  • Diagnosed psychiatric disorders or significant social factors that may prevent adherence to study requirements or completion of follow-up evaluations.
  • Inability to self-administer vaginal gel or vaginal rehabilitation exercises.

结局指标

主要结局

Female Sexual Function Index (FSFI) score

时间窗: From enrollment to the end of intervention at at 3, 6, and 12 months

Female Sexual Function Index (FSFI) score. The score ranges from a minimum of 2 to a maximum of 36. Higher scores indicate better sexual function.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

National Taiwan University Clinical Trial Center

Jenny Ling-Yu Chen, MD PhD

National Taiwan University Hospital

研究点 (1)

Loading locations...

相似试验